
Xuheng Bio
普珩生物
Xuheng Bio
Biotech/Healthcare
Xuheng Bio is a tumor cell immunotherapy service provider. It owns GMP-grade virus production and GMP-grade cell production facilities, providing users with products and services including novel tumor acidic microenvironment-activated CAR-T products and chimeric antigen receptor (CAR)-T cell…
Latest round: Series A (2018)
Source: ChinaBulls — chinabulls.com
Last updated 2018-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.